Total Payments
$4,212
2024 Payments
$434.71
Companies
27
Transactions
211
Medicare Patients
4,957
Medicare Billing
$516,398
Payment Breakdown by Category
Food & Beverage$3,475 (82.5%)
Other$522.00 (12.4%)
Education$215.62 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,475 | 200 | 82.5% |
| Current or prospective ownership or investment interest | $522.00 | 1 | 12.4% |
| Education | $215.62 | 5 | 5.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$4,212
206 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,634 | 91 | $0 (2024) |
| Innovative Medical Technologies, LLC | $522.00 | 6 | $0 (2021) |
| PFIZER INC. | $308.22 | 24 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $268.37 | 15 | $0 (2019) |
| ABBVIE INC. | $233.34 | 13 | $0 (2024) |
| Boston Scientific Corporation | $192.27 | 7 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $136.72 | 8 | $0 (2019) |
| Dornier MedTech America, Inc | $130.53 | 1 | $0 (2024) |
| NeoTract Inc. | $78.34 | 5 | $0 (2020) |
| Tolmar, Inc. | $72.83 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $434.71 | 17 | Dornier MedTech America, Inc ($130.53) |
| 2023 | $273.52 | 13 | Sumitomo Pharma America, Inc. ($70.42) |
| 2022 | $43.09 | 2 | ABBVIE INC. ($29.51) |
| 2021 | $127.77 | 11 | Astellas Pharma US Inc ($87.73) |
| 2020 | $353.89 | 21 | Astellas Pharma US Inc ($273.84) |
| 2019 | $1,051 | 55 | Astellas Pharma US Inc ($465.87) |
| 2018 | $787.66 | 50 | Astellas Pharma US Inc ($368.32) |
| 2017 | $1,140 | 42 | Innovative Medical Technologies, LLC ($522.00) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: UROLOGY | ||||||
| 06/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | Dornier MedTech America, Inc | Dornier MedTech (Device) | Food and Beverage | Cash or cash equivalent | $130.53 | General |
| Category: Not Applicable | ||||||
| 05/22/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Urology | ||||||
| 05/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/01/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: rezum_URO | ||||||
| 02/28/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $23.24 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 02/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: UROLOGY | ||||||
| 01/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Urology | ||||||
| 01/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: rezum_URO | ||||||
| 11/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: UROLOGY | ||||||
| 10/04/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Prostate Cancer | ||||||
| 08/31/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Urology | ||||||
| 07/11/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: UROLOGY | ||||||
| 06/05/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 979 | 1,191 | $382,128 | $89,102 |
| 2022 | 18 | 1,102 | 1,320 | $400,268 | $97,701 |
| 2021 | 28 | 1,411 | 1,766 | $657,141 | $157,643 |
| 2020 | 27 | 1,465 | 2,030 | $683,824 | $171,952 |
Total Patients
4,957
Total Services
6,307
Medicare Billing
$516,398
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 419 | 553 | $81,844 | $23,674 | 28.9% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 25 | 33 | $54,351 | $14,065 | 25.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 22 | 26 | $45,657 | $8,215 | 18.0% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 82 | 87 | $46,980 | $7,950 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 92 | 119 | $25,466 | $7,629 | 30.0% |
| 53854 | Destruction of prostate tissue using radiofrequency induced heated water vapor | Facility | 2023 | 15 | 15 | $16,335 | $4,283 | 26.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 49 | 52 | $11,960 | $3,203 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 29 | $8,990 | $2,888 | 32.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 30 | $20,889 | $2,853 | 13.7% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 13 | 15 | $15,015 | $2,628 | 17.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 38 | 39 | $15,911 | $2,141 | 13.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 19 | 19 | $8,896 | $1,784 | 20.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 31 | 46 | $5,576 | $1,740 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $5,274 | $1,648 | 31.2% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 12 | 13 | $7,475 | $1,153 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 18 | 18 | $3,276 | $1,044 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $2,697 | $902.64 | 33.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 28 | 28 | $2,087 | $529.16 | 25.4% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 17 | 17 | $1,853 | $408.68 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 19 | 19 | $1,596 | $364.88 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 427 | 517 | $76,516 | $21,399 | 28.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 36 | 46 | $77,409 | $21,016 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 148 | 178 | $38,092 | $11,069 | 29.1% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2022 | 87 | 92 | $49,680 | $8,762 | 17.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 14 | 16 | $27,056 | $5,102 | 18.9% |
About Dr. Patrick Dugan, M.D
Dr. Patrick Dugan, M.D is a Urology healthcare provider based in Parkersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932141991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Dugan, M.D has received a total of $4,212 in payments from pharmaceutical and medical device companies, with $434.71 received in 2024. These payments were reported across 211 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,475).
As a Medicare-enrolled provider, Dugan has provided services to 4,957 Medicare beneficiaries, totaling 6,307 services with total Medicare billing of $516,398. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Parkersburg, WV
- Active Since 06/12/2006
- Last Updated 04/18/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1932141991
Products in Payments
- XTANDI (Drug) $729.18
- MYRBETRIQ (Drug) $504.07
- Myrbetriq (Drug) $417.80
- ELIGARD (Drug) $341.20
- BOTOX (Biological) $160.73
- XIAFLEX (Biological) $136.72
- OBTRYX (Device) $130.74
- Dornier MedTech (Device) $130.53
- Androgel (Drug) $82.66
- UroLift (Device) $78.34
- GEMTESA (Drug) $70.42
- KEYTRUDA (Biological) $68.39
- Axonics (Device) $62.67
- TOVIAZ (Drug) $59.43
- Noctiva (Drug) $58.51
- Nubeqa (Drug) $58.19
- AQUABEAM SYSTEM (Device) $42.24
- PROLARIS (Device) $36.37
- (815) Thiola (Drug) $27.55
- Rezum Generator (Device) $27.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.